phosphofructokinase, Platelet (PFKP) (C-Term) Peptid

Details zu Produkt Nr. ABIN981621, Anbieter: Anmelden zum Anzeigen
Proteinname
  • pfk
  • pfk-c
  • pfkf
  • PFKP
  • PFK-C
  • PFKF
  • 1200015H23Rik
  • 9330125N24Rik
  • PFKM
  • phosphofructokinase, platelet
  • phosphofructokinase, platelet S homeolog
  • ATP-dependent 6-phosphofructokinase, platelet type
  • pfkp
  • PFKP
  • pfkp.S
  • LOC100549777
  • Pfkp
Protein Region
C-Term
Spezies
Human
2
2
2
2
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Geblockter Antikörper anti-PFKP Antikörper (phosphofructokinase, Platelet) (C-Term) (ABIN2788927)
Sequenz EWITAKLKEA RGRGKKFTTD DSICVLGISK RNVIFQPVAE LKKQTDFEHR
Produktmerkmale This is a synthetic peptide designed for use in combination with anti-PFKP Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Reinigung Purified
Hintergrund The PFKP gene encodes the platelet isoform of phosphofructokinase (PFK) (ATP:D-fructose-6-phosphate-1-phosphotransferase, EC 2.7.1.11). PFK catalyzes the irreversible conversion of fructose-6-phosphate to fructose-1,6-bisphosphate and is a key regulatory enzyme in glycolysis. The PFKP gene, which maps to chromosome 10p, is also expressed in fibroblasts. See also the muscle (PFKM, MIM 610681) and liver (PFKL, MIM 171860) isoforms of phosphofructokinase, which map to chromosomes 12q13 and 21q22, respectively. Vora (1981) [PubMed 6451249] determined that full tetrameric phophofructokinase enzyme expressed in platelets can be composed of subunits P4, P3L, and P2L2.

Alias Symbols: FLJ40226, PFK-C, PFKF

Protein Interaction Partner: DYNLL1,DMWD,GBAS,MCC,UBC,WIPI2

Protein Size: 784
Molekulargewicht 85 kDa
Gen-ID 5214
NCBI Accession NM_002627, NP_002618
UniProt Q01813
Applikations-hinweise Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Lyophilized
Rekonstitution Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration 1 mg/mL
Buffer Final peptide concentration is 1 mg/mL in PBS.
Handhabung Avoid repeated freeze-thaw cycles.
Lagerung -20 °C
Informationen zur Lagerung For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.